CHICAGO--(BUSINESS WIRE)--Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced the launch of Focus ...
Artificial intelligence (AI) is expanding clinical trial access and enabling drug repurposing, according to Vivek Subbiah, MD. He adds that AI supports drug repurposing by uncovering new actionable ...
Frequency of efficacy, toxicity and cost as the deciding factor when determining clinical pathways. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback